article thumbnail

Considerations for Neuroscience Trials with Intrathecal Delivery and Other Methods of Direct CNS Administration

XTalks

A major obstacle for CNS drug developers is the inability to target therapies to the CNS broadly (for instance, a therapy that is orally bioavailable as a pill and has difficulty crossing the blood-brain barrier) and certain CNS regions more specifically. The patients are waiting! Modern-Day Applications of Direct CNS Administration.

Trials 83
article thumbnail

World Parkinson’s Day 2023 and Promising Parkinson’s Disease Treatments

XTalks

By avoiding the stomach entirely, there is increased bioavailability and more sustained relief from symptoms. Promising Treatments for Parkinson’s Disease Although there is currently no cure for Parkinson’s disease, there are combinations of medications, surgical treatments and other therapies that can relieve symptoms in patients.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

ProstaStream

The Pharma Data

Plus considering that it takes our manufacturing facility 3 whole months to source and produce just a single batch of ProstaStream and that each capsule contains the purest and most bioavailable form of these prostate-supporting power foods in existence…. Statements on this website have not been evaluated by the Food and Drug Administration.

article thumbnail

New Phase 3 Data Show TAK-620 (maribavir), an Investigational Drug for the Treatment of Transplant Recipients with Refractory/Resistant Cytomegalovirus (CMV) Infections, Meets Primary Endpoint

The Pharma Data

Maribavir, an orally bioavailable anti-CMV compound, is the only antiviral agent presently in Phase 3 development for the treatment of post-transplant patients with CMV in SOT or HSCT. The European Blood and Marrow Transplantation Textbook for Nurses: under the Auspices of EBMT. About Maribavir. American Journal of Transplantation.

Drugs 52